Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway. (Q54492986)

30 May 2018

title

Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway. (English)

1 reference

30 May 2018

0 references

1 reference

1 reference

Nan Li

1

1 reference

30 May 2018

Xiaodong Bu

2

1 reference

30 May 2018

Xiaoqiang Tian

3

1 reference

30 May 2018

Peng Wu

4

1 reference

30 May 2018

Lin Yang

5

1 reference

30 May 2018

Peilin Huang

6

1 reference

30 May 2018

publication date

3 August 2012

1 reference

30 May 2018

published in

Nutrition and Cancer

1 reference

30 May 2018

volume

64

1 reference

30 May 2018

issue

6

1 reference

30 May 2018

page(s)

864-870

1 reference

30 May 2018

On the Origin of Cancer Cells

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Fatty acid synthase as a potential therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Fatty acid synthase, a proficient multifunctional enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Signalling through the lipid products of phosphoinositide-3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Phosphoinositide 3-kinases in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

PI3K: downstream AKTion blocks apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Ras, PI3K/Akt and senescence: Paradoxes provide clues for pancreatic cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Activation of the PI3K/AKT pathway in Merkel cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

In vitro evaluation of pan-PI3-kinase inhibitor SF1126 in trastuzumab-sensitive and trastuzumab-resistant HER2-over-expressing breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.701704

10.1080/01635581.2012.701704

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

22860766

1 reference

30 May 2018